Plasma from individuals who have recovered from COVID-19 could benefit sick patients, but definitive evidence for or against convalescent plasma is still lacking. A consensus about how it should be deployed is beginning to emerge—and tools and insights to guide its use are becoming available.

中文翻译：

---

在第一项随机试验中，恢复期血浆表现持平。


来自 COVID-19 康复者的血浆可以使病人受益，但仍然缺乏支持或反对恢复期血浆的明确证据。关于如何部署它的共识正在开始出现，并且指导其使用的工具和见解也正在变得可用。